UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Liberty Global Class A
LBTYA
$3.6B
| $2.79M | ﹤0.01% |
160,265
-4,543,624
| -97% | -$76.9M |
|
1802
US Physical Therapy
USPH
$1.22B
| $2.79M | ﹤0.01% |
30,183
+11,251
| +59% | +$1.14M |
|
1803
Worthington Enterprises
WOR
$2.86B
| $2.79M | ﹤0.01% |
58,915
+29,048
| +97% | +$1.64M |
|
1804
CRA International
CRAI
$1.06B
| $2.79M | ﹤0.01% |
16,191
+4,649
| +40% | +$753K |
|
1805
Clarivate
CLVT
$1.16B
| $2.78M | ﹤0.01% |
488,588
-148,374
| -23% | -$946K |
|
|
LTC
1806
LTC Properties
LTC
$2.15B
| $2.78M | ﹤0.01% |
80,564
-218,969
| -73% | -$7.3M |
|
1807
Mercury Insurance
MCY
$6.07B
| $2.76M | ﹤0.01% |
51,973
+18,608
| +56% | +$1.01M |
|
1808
A10 Networks
ATEN
$1.95B
| $2.76M | ﹤0.01% |
199,258
+84,290
| +73% | +$1.2M |
|
1809
United Microelectronic
UMC
$46.9B
| $2.76M | ﹤0.01% |
315,000
+276,900
| +727% | +$2.28M |
|
1810
Nabors Industries
NBR
$1.21B
| $2.75M | ﹤0.01% |
38,629
+24,008
| +164% | +$1.79M |
|
1811
Arbor Realty Trust
ABR
$998M
| $2.75M | ﹤0.01% |
191,401
+38,503
| +25% | +$515K |
|
1812
Sally Beauty Holdings
SBH
$1.58B
| $2.74M | ﹤0.01% |
255,187
+107,583
| +73% | +$1.18M |
|
1813
Fluence Energy
FLNC
$2.44B
| $2.74M | ﹤0.01% |
157,812
+101,441
| +180% | +$1.95M |
|
1814
ANI Pharmaceuticals
ANIP
$1.78B
| $2.74M | ﹤0.01% |
42,971
+27,435
| +177% | +$1.78M |
|
1815
Schneider National
SNDR
$6.25B
| $2.73M | ﹤0.01% |
112,901
+30,037
| +36% | +$664K |
|
1816
PDF Solutions
PDFS
$2.07B
| $2.72M | ﹤0.01% |
74,777
+40,713
| +120% | +$1.36M |
|
1817
Middlesex Water
MSEX
$1.1B
| $2.7M | ﹤0.01% |
51,713
+19,037
| +58% | +$988K |
|
1818
Compass
COMP
$9.66B
| $2.7M | ﹤0.01% |
750,586
+327,534
| +77% | +$1.2M |
|
1819
AvePoint
AVPT
$2.71B
| $2.7M | ﹤0.01% |
258,689
+85,066
| +49% | +$738K |
|
|
CLLS
1820
Cellectis
CLLS
$285M
| $2.69M | ﹤0.01% |
+1,438,255
| New | +$3.77M |
|
1821
Nurix Therapeutics
NRIX
$2.65B
| $2.69M | ﹤0.01% |
+128,671
| New | +$2M |
|
1822
Urban Edge Properties
UE
$2.73B
| $2.68M | ﹤0.01% |
145,334
-537,032
| -79% | -$9.22M |
|
1823
BioCryst Pharmaceuticals
BCRX
$2.4B
| $2.68M | ﹤0.01% |
432,903
+185,929
| +75% | +$1.03M |
|
1824
Apogee Enterprises
APOG
$908M
| $2.67M | ﹤0.01% |
42,536
+9,908
| +30% | +$616K |
|
1825
Adient
ADNT
$1.5B
| $2.66M | ﹤0.01% |
107,810
-12,087
| -10% | -$343K |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.